Events

Save the date! We are presenting at the 27th Annual @American Society of Gene & Cell Therapy (#ASGCT) Meeting next week in Baltimore, MD! 📌

We’re thrilled to share that our CEO Jean-Philippe Combal will join a panel of key industry leaders at the 10th Annual LSX World Congress to provide insight on best

Paris, France, April 23, 2024 – Vivet Therapeutics (“Vivet”), a clinical stage biotech company developing novel and long-lasting gene therapies for rare inherited liver metabolic

Vivet Therapeutics Co-founder and Chief Scientific Officer, Gloria Gonzalez-Aseguinolaza will be participating in a round table discussion on ‘Therapeutic Advances’ on the ‘Current Situation of

Vivet Therapeutics is heading to Rome for the 2024 Cell & Gene Meeting on the Med from 9 – 11 April. Come and listen to

Vivet Therapeutics Chief Executive Officer, Jean-Philippe Combal will be attending the 7th Annual Gene Therapy for Rare Disorders Summit, taking place from 26-29 March in

The Vivet Therapeutics team had the honor of sponsoring and attending the Spanish Wilson’s Disease Association meeting in Valencia, Spain (learn more: https://lnkd.in/eUMB-AUw ) over the

Vivet Therapeutics is pleased to join AASLD – The Liver Meeting  in Boston, MA this year. Meet with Vivet Therapeutics for an update on the

Excited to kick off ESGCT’s 30th Annual Congress in Brussels today! Join Vivet’s New Programs and Innovation Lead @Nicholas Weber, Ph.D. as he presents on